Posted in | News

Accelergy Obtains Funding to Construct Pilot Test Facility

Accelergy, declared that it has obtained $1.3 million funding from the Commonwealth of Pennsylvania to commence the construction of a facility at Intertek PARC, situated at the U-PARC facility in Pittsburgh.

The new facility will showcase the company’s integrated coal-biomass-to-liquids (CBTL) technology platform. Earlier, the company had received a $175,000 as fund to perform a feasibility study and zero in on the location of the facility.

The new funding will enable Accelergy and its associates to demonstrate the integrated procedure of converting coal into liquids and acknowledge the development of a full-fledged commercial level production facility in the state. The facility will allow Accelergy to generate and test a range of non-petroleum fuel products such as diesel, gasoline, and jet fuel. It will also deploy a process that will utilize algae to change the carbon dioxide into extra fuels in the liquid form and a bio-fertilizer.

General Manager of the Intertek PARC facility, Dr. Robert Absil, stated that Intertek will offer its technical and scientific pilot plant and laboratory assistance to Accelergy Energy Strategy Environment, a systems integrating company that will bring in the much needed technologies and business associates required for the recycle process and carbon capture of the project.

Currently, Accelergy has signed an accord with the U.S. Army Tank Automotive Research, Development and Engineering (TARDEC) Center and the U.S. Air Force Research Laboratory to evaluate and certify the produced fuels for various purposes.

Source: http://www.accelergy.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Accelergy Obtains Funding to Construct Pilot Test Facility. AZoBuild. Retrieved on November 22, 2024 from https://www.azobuild.com/news.aspx?newsID=13884.

  • MLA

    Scanlon, Joel. "Accelergy Obtains Funding to Construct Pilot Test Facility". AZoBuild. 22 November 2024. <https://www.azobuild.com/news.aspx?newsID=13884>.

  • Chicago

    Scanlon, Joel. "Accelergy Obtains Funding to Construct Pilot Test Facility". AZoBuild. https://www.azobuild.com/news.aspx?newsID=13884. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. Accelergy Obtains Funding to Construct Pilot Test Facility. AZoBuild, viewed 22 November 2024, https://www.azobuild.com/news.aspx?newsID=13884.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.